Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer.
| Autor: | Luboff, Alexa J., DeRemer, David L. |
|---|---|
| Zdroj: | Annals of Pharmacotherapy; Dec2024, Vol. 58 Issue 12, p1229-1237, 9p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|